COMP <GO>
MKSI vs TMO // RSI-14 & 200D SMA MOMENTUM
MKS Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MKSI 7
— TMO 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $202.04 (-6.54%) • MKT CAP: $14.62B
rsi-technicals
34.3
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
rsi-technicals
59.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MKSI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MKSI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.70% | 41.00% | +5.70 | MKSI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.60% | 9.30% | -0.70 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 25.6x | 30.4x | -4.80 | MKSI | /valuation <GO> |
| Free Cash Flow Yield | 3.40% | 2.40% | +1.00 | MKSI | /fcf-yield <GO> |
| Operating Margin | 13.40% | 17.40% | -4.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 7.50% | 15.10% | -7.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.60% | 3.90% | +5.70 | MKSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.40% | 0.24% | +0.16 | MKSI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.42 | 4.50 | -2.08 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | MKSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.70% | +0.20 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 34.3 | 59.1 | -24.90 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.94 | +0.06 | MKSI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 46.0x | 36.3x | +9.70 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.62B | $262.22B | -$247.60B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MKSI REV | TMO REV | MKSI GROSS % | TMO GROSS % | MKSI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.93B | $44.56B | 46.7% | 44.0% | $497.0M | $6.29B |
| FY 2024 | $3.59B | $42.88B | 47.6% | 44.0% | $410.0M | $7.27B |
| FY 2023 | $3.62B | $42.86B | 44.0% | 44.0% | $156.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MKSI // BETA 1.00
TMO // BETA 0.94